Navinta Appeals Infringement Ruling Over Naropin
Generic-drug manufacturer Navinta LLC has appealed a ruling that it is liable for infringing three patents for Abraxis BioScience Inc.'s injectable pain management drug Naropin....To view the full article, register now.
Already a subscriber? Click here to view full article